tegafur has been researched along with Invasiveness, Neoplasm in 114 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This phase II study evaluated the efficacy and safety of anastrozole concurrent with tegafur/uracil (UFT) as neoadjuvant therapy for ER-positive postmenopausal breast cancer." | 9.27 | Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC). ( Aono, T; Ito, T; Kagimura, T; Masuda, N; Matsunami, N; Miyoshi, Y; Nakayama, T; Noguchi, S; Sagara, Y; Taguchi, T; Takashima, T, 2018) |
| " We investigated the benefits of oral protein-bound polysaccharide K (PSK) with tegafur/uracil (UFT) as an adjuvant in stage II and III colorectal cancer." | 9.11 | Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. ( Ikeya, T; Ishikawa, H; Iwazaki, S; Kakinuma, S; Kawate, S; Kusaba, T; Morishita, Y; Nakajima, T; Nakamura, S; Ohwada, S; Roppongi, T; Takahashi, T; Yokomori, T, 2004) |
| "This phase II study evaluated the efficacy and safety of anastrozole concurrent with tegafur/uracil (UFT) as neoadjuvant therapy for ER-positive postmenopausal breast cancer." | 5.27 | Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC). ( Aono, T; Ito, T; Kagimura, T; Masuda, N; Matsunami, N; Miyoshi, Y; Nakayama, T; Noguchi, S; Sagara, Y; Taguchi, T; Takashima, T, 2018) |
| " We investigated the benefits of oral protein-bound polysaccharide K (PSK) with tegafur/uracil (UFT) as an adjuvant in stage II and III colorectal cancer." | 5.11 | Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. ( Ikeya, T; Ishikawa, H; Iwazaki, S; Kakinuma, S; Kawate, S; Kusaba, T; Morishita, Y; Nakajima, T; Nakamura, S; Ohwada, S; Roppongi, T; Takahashi, T; Yokomori, T, 2004) |
| "The objectives of this study were to evaluate the efficacy and toxicity of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur (UFT) in patients with advanced adenocarcinoma of the pancreas." | 5.10 | Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas. ( Bolaños, M; Borrega, P; Castro, J; Dorta, J; Escudero, P; Espinosa, E; Feliu, J; González Barón, M; López Gómez, L; Mel, R; Vázquez-Estévez, SE, 2002) |
| "Metronomic chemotherapy using the 5-FU prodrug uracil-tegafur (UFT) and cyclophosphamide (CTX) was previously shown to only modestly delay primary tumor growth, but nevertheless markedly suppressed the development of micro-metastasis in an orthotopic breast cancer xenograft model, using the metastatic variant of the MDA-MB-231 cell line, 231/LM2-4." | 3.91 | Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion. ( Cruz-Muñoz, W; Hileeto, D; Kerbel, RS; Man, S; Muñoz, R; Viloria-Petit, A; Wood, GA; Xu, P, 2019) |
| "We treated a patient with inoperable advanced gastric cancer and malignant ascites by combination chemotherapy of TS-1 and biweekly paclitaxel (TXL)." | 3.72 | [A patient with advanced gastric cancer that response remarkably to combination chemotherapy of TS-1 and biweekly paclitaxel (TXL)]. ( Funai, S; Hirai, T; Kamei, A; Ohtsuka, H; Shindo, K; Shiozaki, H; Tanaka, A; Yoshifuji, T, 2003) |
| " The other 36 received CRC at the same cisplatin and radiotherapy dosage as for CRSC." | 2.82 | Concurrent radiotherapy with S-1 plus cisplatin versus concurrent radiotherapy with cisplatin alone for the treatment of locally advanced cervical carcinoma: a pilot randomised controlled trial. ( Han, S; Li, Z; Lin, N; Mao, W, 2016) |
| "An 80-year-old man with a local recurrence of gastric cancer was treated with S-1 monotherapy leading to a complete response(CR)." | 2.53 | [An Elderly Patient with Local Recurrence of Gastric Cancer Responding Completely to S-1 Monotherapy]. ( Hasegawa, M; Ichikawa, K; Kokado, Y; Koshiba, T; Kusama, T; Sone, N; Yamagami, K, 2016) |
| "A 72-year-old man with advanced gastric cancer was referred to our hospital." | 2.49 | [A case of locally advanced gastric cancer in which pathological complete response( PCR) was obtained after combination chemotherapy with S-1/cisplatin]. ( Fujino, M; Hasegawa, A; Kametaka, H; Koyama, T; Makino, H; Matsuo, M; Seike, K; Yokoyama, M, 2013) |
| "Unresectable pancreatic cancer (UR-PC) has a poor prognosis." | 1.56 | Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy. ( Endo, I; Kumamoto, T; Matsuyama, R; Murakami, T; Sawada, Y; Tsuchiya, N; Yabushita, Y, 2020) |
| "The patient with gallbladder cancer and tumor thrombus in the portal vein described in this report provides a reminder for surgeons of the importance of early diagnosis, and adequate surgical and adjuvant treatment." | 1.48 | Gallbladder cancer with tumor thrombus in the portal vein: A case report. ( Bai, XL; Chen, W; Liang, TB; Ma, T; Tu, JJ; Zhang, XZ, 2018) |
| "We encountered a case of type 4 gastric cancer with esophageal invasion that responded to neoadjuvant chemotherapy containing S-1 and oxaliplatin(SOX)followed by surgery, which could be curative resection." | 1.48 | [A Case of Type 4 Gastric Cancer with Esophageal Invasion That Responded to Neoadjuvant Chemotherapy Containing S-1 and Oxaliplatin followed by Surgery]. ( Fujimura, T; Hagino, S; Izumi, R; Kitagawa, H; Kurata, T; Saito, K; Sasaki, S; Shoji, Y; Terada, I; Yoshikawa, A, 2018) |
| "On the other hand, the 2014 Japanese gastric cancer treatment guidelines(ver." | 1.46 | [A Case of Duodenal Invasive Advanced Gastric Cancer in Which the Primary Tumor Achieved pCR, but Viable Cancer Cells Remained in Lymph Node No.13 after Neoadjuvant Chemotherapy]. ( Choda, Y; Harano, M; Idani, H; Ishida, M; Kubota, T; Matsukawa, H; Miyake, S; Morito, T; Nakano, K; Ojima, Y; Okajima, M; Sato, D; Shiozaki, S; Sumitani, D, 2017) |
| "The prognosis of advanced gastric cancer was significantly related to the start of S-1 adjuvant treatment within 6 weeks after surgery." | 1.43 | S-1 Adjuvant Chemotherapy Earlier After Surgery Clinically Correlates with Prognostic Factors for Advanced Gastric Cancer. ( Egashira, A; Ikeda, Y; Kinjo, N; Minami, K; Morita, M; Okamura, T; Sakaguchi, Y; Toh, Y; Yamaguchi, S; Yamamoto, M, 2016) |
| "The prognosis of Stage IV b pancreatic cancer is extremely poor; the mean survival time is 2-4 months." | 1.42 | [A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy]. ( Fujino, Y; Goto, H; Hasegawa, H; Kakinoki, K; Katsura, M; Ohara, T; Oshikiri, T; Oyama, M; Sendo, H; Sugimoto, T; Sugiyama, H; Tominaga, M; Ueda, Y; Yamashita, H; Yasuda, T, 2015) |
| "The prognosis of patients with advanced gastric cancer is poor." | 1.40 | Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer. ( Chen, XB; Hua, YW; Kong, Y; Liu, HX; Ma, EM; Yang, W; Zhang, B; Zhang, YL; Zhang, ZD, 2014) |
| "A 62-year-old woman diagnosed with gallbladder cancer exhibiting broad liver invasion and metastasis to Couinaud's hepatic segments 4 and 8 (S4 and S8) consulted her regular doctor." | 1.40 | Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case. ( Ide, T; Ide, Y; Kai, K; Kitahara, K; Koga, H; Miyoshi, A; Nakamura, H; Nakamura, J; Noshiro, H; Okumura, T, 2014) |
| "A total of 59 patients with stage IV gastric cancer received induction chemotherapy with S-1 and cisplatin." | 1.40 | Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients. ( Kiyozaki, H; Rikiyama, T; Saito, M; Suzuki, K; Takata, O, 2014) |
| "A 6 2-year-old man with advanced gastric cancer was referred to our hospital." | 1.40 | [Pathological complete response in a case of advanced gastric cancer after neoadjuvant chemotherapy]. ( Fujiwara, T; Kagawa, S; Kikuchi, S; Kubota, T; Kuroda, S; Kuwada, K; Nishizaki, M; Tanaka, T, 2014) |
| "Medical records of 133 patients with extrahepatic cholangiocarcinoma who underwent curative resection were reviewed retrospectively." | 1.39 | Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies. ( Hashimoto, Y; Kondo, N; Murakami, Y; Muto, T; Nakagawa, N; Sasaki, H; Sudo, T; Sueda, T; Uemura, K; Urabe, K, 2013) |
| "Advanced gastric cancer was found at the fundus of the stomach, and severe dysplasia was found at the lower esophagus." | 1.38 | [A case of advanced gastric cancer with esophageal severe dysplasia resected after neoadjuvant S-1+cisplatin therapy]. ( Hosaka, S; Inada, K; Kawamoto, S; Kikutake, T; Maeno, H; Nagao, S; Okubo, S; Umemoto, S; Yoshida, T, 2012) |
| "We experienced two cases of Stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy." | 1.38 | [Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy]. ( Azuma, T; Inoue, T; Mori, Y; Ohtani, H; Tamamori, Y, 2012) |
| "In patients with stage II/III gastric cancer, tumors often recur even after curative D2 gastrectomy followed by adjuvant S-1 chemotherapy." | 1.37 | Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1. ( Aoyama, T; Cho, H; Hayashi, T; Ogata, T; Tsuburaya, A; Watanabe, T; Yoshikawa, T, 2011) |
| "Herein, we report a bladder cancer case with multiple metastases which were controlled by low-dose UFT." | 1.37 | [A case of marked efficacy of low-dose UFT against metastatic bladder cancer]. ( Arai, Y; Ito, A; Kuwahara, M; Nakano, O; Satoh, M, 2011) |
| " The regimen of pre-op CCRT was a radiation dosage of 45 Gy in 20 fractions and oral tegafur-uracil (UFUR) and leucovorin." | 1.36 | The impact of preoperative chemoradiotherapy on advanced low rectal cancer. ( Chang, SC; Chen, WS; Jiang, JK; Kao, PS; Lee, RC; Liang, WY; Lin, JK; Lin, TC; Wang, HS; Wang, LW; Yang, SH, 2010) |
| "In the case of pancreatic cancer that CRT is effective to the remission of primary lesion, CRT is potentially useful to perform for the control of metastatic lesion or palliative therapy." | 1.36 | [A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy]. ( Aoki, H; Choda, Y; Fujiwara, Y; Harano, M; Matsukawa, H; Ninomiya, M; Nishizaki, M; Ohno, S; Ojima, Y; Shiozaki, S; Takakura, N, 2010) |
| "We present a case of esophageal cancer with multiple lymph node metastases successfully performed early response evaluation for preoperative chemotherapy by FDG-PET." | 1.35 | [Case of esophageal cancer successfully performed in early response evaluation for preoperative chemotherapy by FDG-PET]. ( Arakaki, K; Isa, T; Kaneshiro, T; Nakachi, A; Nishimaki, T; Shiroma, H; Teruya, T; Yamamoto, H, 2008) |
| "Examination revealed locally advanced pancreatic cancer with infiltration of the superior mesenteric artery." | 1.35 | Curative surgical treatment after preoperative chemotherapy for primarily inoperable locally advanced pancreatic carcinoma: report of a case. ( Dowaki, S; Hirabayashi, K; Imaizumi, T; Makuuchi, H; Matsuyama, M; Okada, K; Tobita, K; Yazawa, N, 2009) |
| "We report a case of advanced breast cancer (T4b, N3c, M1) achieving a significant improvement on QOL by multi-disciplinary therapy and S-1 administration." | 1.34 | [A case of advanced breast cancer successfully treated with multi-disciplinary therapy and S-1 administration]. ( Amano, S; Enomoto, K; Kitajima, A; Sakurai, K; Tani, M, 2007) |
| "A resected case of squamous cell carcinoma associated with ductal carcinoma in the hemilateral breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases is reported with some discussion." | 1.34 | [A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases]. ( Akagawa, T; Fujioka, S; Hara, T; Hiramatsu, K; Hirata, A; Ito, T; Kato, K; Kutsuna, Y; Machiki, Y; Matsuba, H; Miyata, T, 2007) |
| "Adjuvant chemotherapy for advanced gastric cancer has not yet been established." | 1.34 | [A case of advanced gastric cancer responding remarkably to neo-adjuvant combination chemotherapy using CPT-11 plus S-1]. ( Gotoh, M; Hashimoto, Y; Hoshino, Y; Kashimura, S; Kogure, M; Odashima, Y; Osuka, F; Otani, S; Saito, T; Saze, Z; Soeta, N; Terashima, M; Watanabe, K, 2007) |
| "We report a case of advanced rectal cancer successfully treated with a combination of S-1 and CPT-11 as neoadjuvant chemotherapy." | 1.34 | [Neoadjuvant chemotherapy with combination of S-1 and CPT-11 in advanced rectal cancer - a case report]. ( Han, I; Hatori, S; Iwasaki, H; Murakami, H; Suzuki, M; Takanashi, Y; Yamakawa, M, 2007) |
| "We reported a case of unresectable gastric cancer presenting pylorus stenosis treated orally by S-1 therapy in a 72-year-old man who underwent gastrojejunostomy." | 1.34 | [A case of unresectable gastric cancer presenting pylorus stenosis treated orally with S-1 therapy after gastrojejunostomy]. ( Matsui, K; Morita, S; Shinbo, M; Tazawa, K; Tsukada, K; Yamada, A; Yamagishi, F; Yoshida, T, 2007) |
| "The data on 307 patients with colorectal cancer at stage II or III, who underwent potentially curative resection with lymphadenectomy, were reviewed." | 1.33 | The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer. ( Ikeda, S; Ishibashi, N; Matono, K; Mizobe, T; Ogata, Y; Ogo, S; Ohkita, A; Ozasa, H; Sasatomi, T; Shirouzu, K, 2006) |
| "We report a patient with gastric cancer successfully treated with TS-1 and low-dose CDDP as neoadjuvant chemotherapy." | 1.33 | [A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy]. ( Ebina, T; Kawasaki, H; Kobori, H; Sasaki, M; Seino, K; Shibata, S; Sugiyama, Y; Tanaka, M; Yamada, K, 2005) |
| "A 72-year-old man was diagnosed as gastric cancer with pyloric stenosis by an upper gastorintestinal endoscopy for anemia in July 2001." | 1.33 | [A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months]. ( Ishizuka, D; Kobayashi, K; Tada, T; Ueki, K; Wakakuwa, R, 2006) |
| "We report a case of advanced squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to oral chemotherapy with TS-1." | 1.32 | [An advanced case of squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to chemotherapy with TS-1]. ( Mishima, K; Nakamura, H; Obara, S; Yamamoto, K; Yoshimura, Y, 2004) |
| " Beginning on August 9, 1999, TS-1 was administered in a dosage of 50 mg bid, but it was later learned that the patient had ingested only half of that TS-1 dosage (i." | 1.31 | [A case of residual gastric cancer accompanied by esophageal invasion in which residual lesions were eradicated by half-dose administration of TS-1]. ( Abe, S; Kitago, M; Kojima, M; Kurihara, H; Ogihara, T; Sasanuma, H; Tamura, H; Wada, M, 2002) |
| "In patients with stage 4 gastric cancer, however, MFL treatment showed similar effects as UFT on the postsurgical survival of the patients." | 1.31 | Postsurgical sequential methotrexate, fluorouracil, and leucovorin for stages 3 and 4 gastric carcinoma: A preliminary study. ( Kitaoka, A; Ohsumi, K; Tokuka, A; Tokunaga, Y; Yagi, T, 2000) |
| "Macroscopically it was gastric cancer with P0H3N1T3M0, Stage IV b, histologically small cell carcinoma, intermed, INF gamma, ss, ly1, v3, n1(+), ow(-), aw(-)." | 1.29 | [A case of small cell carcinoma of the stomach with multiple liver metastases]. ( Ishizawa, S; Masuyama, K; Oonishi, Y; Sawataishi, M; Suzuki, S; Wakaki, K; Yamazaki, K, 1994) |
| "A 79-year-old female with hepatocellular carcinoma with portal invasion and right adrenal gland metastasis was treated by low dose UFT (200 mg/day)." | 1.29 | [A case of hepatocellular carcinoma with portal invasion and right adrenal gland metastasis showing marked contraction of primary tumor and metastasis with treated by UFT alone]. ( Itoh, Y; Ohkawa, S; Tamai, S; Tarao, K, 1994) |
| "Influencing factors of recurrence in rectal cancer, such as depth of invasion, ew, vessel invasion (ly, v) and lymph node involvements were improved in the irradiated group, especially in effective cases, as compared with the non-irradiated group." | 1.28 | [Histopathological findings in rectal carcinomas undergoing preoperative irradiation combined with chemotherapy]. ( Takiguchi, N, 1992) |
| "A diagnosis of hepatocellular carcinoma with extrahepatic portal venous obstruction due to tumor invasion was made." | 1.27 | [A case of hepatocellular carcinoma with extrahepatic portal vein obstruction due to tumor invasion, responsive to oral administration of UFT]. ( Kuroda, K; Maeda, S; Nagase, T; Nakagawa, C; Nakanishi, T; Nishikawa, M; Tokunaga, K, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.75) | 18.7374 |
| 1990's | 8 (7.02) | 18.2507 |
| 2000's | 40 (35.09) | 29.6817 |
| 2010's | 61 (53.51) | 24.3611 |
| 2020's | 3 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Muñoz, R | 1 |
| Hileeto, D | 1 |
| Cruz-Muñoz, W | 1 |
| Wood, GA | 1 |
| Xu, P | 1 |
| Man, S | 1 |
| Viloria-Petit, A | 1 |
| Kerbel, RS | 1 |
| Oneyama, M | 1 |
| Sakamoto, N | 2 |
| Oue, N | 1 |
| Kimura, Y | 2 |
| Hiroshima, Y | 1 |
| Hashimoto, I | 1 |
| Hara, K | 2 |
| Maezawa, Y | 1 |
| Kano, K | 1 |
| Aoyama, T | 2 |
| Fujikawa, H | 1 |
| Yamada, T | 2 |
| Tamagawa, H | 2 |
| Yamamoto, N | 1 |
| Ogata, T | 2 |
| Cho, H | 2 |
| Ito, H | 1 |
| Yukawa, N | 1 |
| Shiozawa, M | 1 |
| Yoshikawa, T | 3 |
| Morinaga, S | 1 |
| Rino, Y | 2 |
| Masuda, M | 1 |
| Miyagi, Y | 1 |
| Yasui, W | 1 |
| Oshima, T | 1 |
| Nishibeppu, K | 1 |
| Komatsu, S | 2 |
| Imamura, T | 1 |
| Kiuchi, J | 1 |
| Kishimoto, T | 1 |
| Arita, T | 1 |
| Kosuga, T | 1 |
| Konishi, H | 2 |
| Kubota, T | 3 |
| Shiozaki, A | 2 |
| Fujiwara, H | 3 |
| Okamoto, K | 2 |
| Otsuji, E | 2 |
| Tsuchiya, N | 1 |
| Matsuyama, R | 1 |
| Murakami, T | 1 |
| Yabushita, Y | 1 |
| Sawada, Y | 1 |
| Kumamoto, T | 1 |
| Endo, I | 2 |
| Tsuchiya, T | 3 |
| Kamohara, R | 2 |
| Muraoka, M | 2 |
| Nagayasu, T | 1 |
| Saeki, S | 1 |
| Takenoyama, M | 1 |
| Suzuki, M | 2 |
| Inada, K | 3 |
| Tokunaga, S | 1 |
| Hayashi, T | 2 |
| Urabe, S | 2 |
| Koga, T | 1 |
| Akamine, S | 2 |
| Sugio, K | 2 |
| Choda, Y | 2 |
| Morito, T | 1 |
| Miyake, S | 1 |
| Ishida, M | 2 |
| Sato, D | 1 |
| Sumitani, D | 1 |
| Nakano, K | 1 |
| Harano, M | 2 |
| Matsukawa, H | 2 |
| Ojima, Y | 2 |
| Idani, H | 1 |
| Shiozaki, S | 2 |
| Okajima, M | 1 |
| Gakuhara, A | 1 |
| Miyazaki, Y | 1 |
| Takahashi, T | 3 |
| Kurokawa, Y | 4 |
| Tanaka, K | 1 |
| Makino, T | 1 |
| Yamasaki, M | 2 |
| Nakajima, K | 2 |
| Mori, M | 2 |
| Doki, Y | 1 |
| Nakayama, T | 1 |
| Sagara, Y | 1 |
| Takashima, T | 1 |
| Matsunami, N | 1 |
| Masuda, N | 1 |
| Miyoshi, Y | 1 |
| Taguchi, T | 1 |
| Aono, T | 1 |
| Ito, T | 2 |
| Kagimura, T | 1 |
| Noguchi, S | 1 |
| Zhang, XZ | 1 |
| Tu, JJ | 1 |
| Chen, W | 1 |
| Ma, T | 1 |
| Bai, XL | 1 |
| Liang, TB | 1 |
| Hagino, S | 1 |
| Fujimura, T | 1 |
| Kurata, T | 1 |
| Shoji, Y | 2 |
| Sasaki, S | 1 |
| Terada, I | 1 |
| Yoshikawa, A | 1 |
| Kitagawa, H | 1 |
| Izumi, R | 1 |
| Saito, K | 1 |
| Murakami, Y | 2 |
| Uemura, K | 2 |
| Sudo, T | 2 |
| Hashimoto, Y | 3 |
| Kondo, N | 2 |
| Nakagawa, N | 1 |
| Muto, T | 1 |
| Sasaki, H | 2 |
| Urabe, K | 1 |
| Sueda, T | 2 |
| Kubo, N | 3 |
| Takeuchi, N | 1 |
| Nakayama, A | 1 |
| Ogiwara, H | 1 |
| Masahiro, O | 1 |
| Tsujimoto, K | 1 |
| Ito, N | 1 |
| Shibata, T | 1 |
| Sasako, M | 2 |
| Sano, T | 2 |
| Tsuburaya, A | 3 |
| Iwasaki, Y | 2 |
| Fukuda, H | 1 |
| Murata, A | 1 |
| Kimura, K | 4 |
| Amano, R | 3 |
| Hirata, K | 2 |
| Nagahara, H | 2 |
| Toyokawa, T | 1 |
| Tanaka, H | 2 |
| Muguruma, K | 2 |
| Otani, H | 1 |
| Maeda, K | 3 |
| Ohira, M | 2 |
| Hirakawa, K | 3 |
| Kondo, J | 1 |
| Nisimura, T | 1 |
| Nagashima, Y | 1 |
| Okada, T | 2 |
| Nakamura, M | 2 |
| Setoguchi, M | 1 |
| Yoshino, S | 1 |
| Sakata, K | 1 |
| Fujino, M | 1 |
| Kametaka, H | 1 |
| Makino, H | 2 |
| Yokoyama, M | 1 |
| Matsuo, M | 1 |
| Seike, K | 1 |
| Koyama, T | 1 |
| Hasegawa, A | 1 |
| Maeda, T | 1 |
| Hashimoto, K | 1 |
| Ishida, T | 1 |
| Yamashita, Y | 2 |
| Saeki, H | 1 |
| Kawanaka, H | 1 |
| Uchiyama, H | 1 |
| Ikeda, T | 1 |
| Tsujitani, S | 1 |
| Maehara, Y | 1 |
| Zhang, ZD | 1 |
| Kong, Y | 1 |
| Yang, W | 1 |
| Zhang, B | 1 |
| Zhang, YL | 1 |
| Ma, EM | 1 |
| Liu, HX | 1 |
| Chen, XB | 1 |
| Hua, YW | 1 |
| Tashiro, J | 1 |
| Yamaguchi, S | 2 |
| Ishii, T | 1 |
| Suzuki, A | 1 |
| Kondo, H | 1 |
| Morita, Y | 2 |
| Koyama, I | 1 |
| Yamamura, A | 1 |
| Ono, F | 1 |
| Hiraga, M | 1 |
| Omura, N | 1 |
| Takano, N | 1 |
| Sato, H | 1 |
| Toyama, S | 1 |
| Onochi, S | 1 |
| Omori, K | 1 |
| Wakabayashi, K | 2 |
| Ishibashi, Y | 1 |
| Ito, Y | 1 |
| Okumura, T | 1 |
| Nakamura, J | 1 |
| Kai, K | 1 |
| Ide, Y | 1 |
| Nakamura, H | 2 |
| Koga, H | 1 |
| Ide, T | 1 |
| Miyoshi, A | 1 |
| Kitahara, K | 1 |
| Noshiro, H | 1 |
| Saito, M | 1 |
| Kiyozaki, H | 1 |
| Takata, O | 1 |
| Suzuki, K | 1 |
| Rikiyama, T | 1 |
| Kunisaki, C | 2 |
| Kimura, J | 1 |
| Takagawa, R | 1 |
| Kanazawa, A | 1 |
| Ota, M | 1 |
| Kosaka, T | 1 |
| Ono, HA | 1 |
| Akiyama, H | 1 |
| Kono, E | 1 |
| Tanaka, N | 2 |
| Kudo, K | 1 |
| Musha, H | 1 |
| Miyachi, T | 1 |
| Nagao, M | 1 |
| Kajiwara, T | 1 |
| Kimura, S | 1 |
| Karasawa, H | 1 |
| Aoki, T | 2 |
| Abe, T | 1 |
| Ohnuma, S | 1 |
| Nakagawa, K | 1 |
| Morikawa, T | 1 |
| Yoshida, H | 2 |
| Motoi, F | 2 |
| Katayose, Y | 1 |
| Naito, T | 1 |
| Unno, M | 2 |
| Hokonohara, K | 1 |
| Takata, A | 1 |
| Imamura, H | 2 |
| Hirota, M | 1 |
| Oshima, K | 1 |
| Tanida, T | 1 |
| Hatano, H | 1 |
| Noda, T | 1 |
| Komori, T | 1 |
| Morita, S | 3 |
| Iwazawa, T | 1 |
| Akagi, K | 1 |
| Adachi, S | 1 |
| Dono, K | 1 |
| Kikuchi, S | 2 |
| Kagawa, S | 1 |
| Kuwada, K | 1 |
| Kuroda, S | 1 |
| Nishizaki, M | 2 |
| Tanaka, T | 1 |
| Fujiwara, T | 1 |
| Shimizu, K | 1 |
| Yukawa, T | 1 |
| Okita, R | 1 |
| Saisho, S | 1 |
| Maeda, A | 1 |
| Nojima, Y | 1 |
| Nakata, M | 1 |
| Nakata, B | 1 |
| Yamazoe, S | 1 |
| Motomura, H | 1 |
| Yamamoto, A | 1 |
| Tanaka, S | 3 |
| Ohara, T | 1 |
| Fujino, Y | 1 |
| Goto, H | 2 |
| Yamashita, H | 1 |
| Oyama, M | 1 |
| Katsura, M | 1 |
| Sugiyama, H | 1 |
| Ueda, Y | 2 |
| Hasegawa, H | 1 |
| Yasuda, T | 1 |
| Kakinoki, K | 1 |
| Oshikiri, T | 1 |
| Sendo, H | 1 |
| Sugimoto, T | 1 |
| Tominaga, M | 1 |
| Li, Z | 1 |
| Mao, W | 1 |
| Lin, N | 1 |
| Han, S | 1 |
| Yamamoto, M | 2 |
| Sakaguchi, Y | 1 |
| Kinjo, N | 1 |
| Egashira, A | 1 |
| Minami, K | 1 |
| Ikeda, Y | 1 |
| Morita, M | 2 |
| Toh, Y | 1 |
| Okamura, T | 1 |
| Yokotani, T | 1 |
| Inatsugi, N | 1 |
| Yoshikawa, S | 1 |
| Masuda, T | 1 |
| Uchida, H | 1 |
| Kuge, H | 1 |
| Yamaoka, K | 1 |
| Shimobayashi, T | 1 |
| Inagaki, M | 1 |
| Yokoo, T | 1 |
| Kurisaki, M | 1 |
| Miyazawa, Y | 1 |
| Sho, M | 1 |
| Goto, T | 1 |
| Toyama, H | 1 |
| Asari, S | 1 |
| Terai, S | 1 |
| Kinoshita, H | 2 |
| Matsumoto, T | 1 |
| Kuramitsu, K | 1 |
| Tanaka, M | 2 |
| Takebe, A | 1 |
| Kido, M | 1 |
| Matsumoto, I | 1 |
| Ajiki, T | 1 |
| Fukumoto, T | 1 |
| Ku, Y | 1 |
| Kim, SG | 1 |
| Hwang, SH | 1 |
| Kusama, T | 1 |
| Yamagami, K | 1 |
| Hasegawa, M | 1 |
| Sone, N | 1 |
| Kokado, Y | 1 |
| Koshiba, T | 1 |
| Ichikawa, K | 1 |
| Iwamoto, M | 1 |
| Takahashi, Y | 2 |
| Fujioka, H | 1 |
| Sato, N | 1 |
| Terasawa, R | 1 |
| Kawaguchi, K | 1 |
| Ikari, A | 1 |
| Tominaga, T | 1 |
| Maezawa, S | 1 |
| Umezaki, N | 1 |
| Matsuda, J | 1 |
| Uchiyama, K | 1 |
| Koh, M | 1 |
| Kishi, K | 1 |
| Tsukada, R | 1 |
| Tanemura, M | 1 |
| Tei, M | 1 |
| Masuzawa, T | 1 |
| Suzuki, Y | 1 |
| Furukawa, K | 1 |
| Ikehara, M | 1 |
| Akamatsu, H | 1 |
| Zhu, Y | 1 |
| Sun, Y | 1 |
| Hu, S | 1 |
| Jiang, Y | 1 |
| Yue, J | 1 |
| Xue, X | 1 |
| Yang, L | 1 |
| Xue, L | 1 |
| Isa, T | 1 |
| Kaneshiro, T | 1 |
| Yamamoto, H | 1 |
| Nakachi, A | 1 |
| Teruya, T | 1 |
| Shiroma, H | 1 |
| Arakaki, K | 1 |
| Nishimaki, T | 1 |
| Lee, JJ | 1 |
| Kim, SY | 1 |
| Chung, HC | 1 |
| Lee, KH | 1 |
| Song, HS | 1 |
| Kang, WK | 1 |
| Hong, YS | 1 |
| Choi, IS | 1 |
| Lee, YY | 1 |
| Woo, IS | 1 |
| Choi, JH | 1 |
| Takada, J | 1 |
| Okuda, K | 1 |
| Kenno, S | 1 |
| Shimada, S | 1 |
| Oba, G | 1 |
| Shimokuni, T | 1 |
| Hamada, H | 1 |
| Park, IJ | 1 |
| Choi, GS | 1 |
| Lim, KH | 1 |
| Kang, BM | 1 |
| Jun, SH | 1 |
| Igishi, T | 1 |
| Shigeoka, Y | 1 |
| Yasuda, K | 1 |
| Suyama, H | 1 |
| Katayama, S | 1 |
| Sugitani, A | 1 |
| Matsumoto, S | 1 |
| Takeda, K | 1 |
| Sumikawa, T | 1 |
| Sako, T | 1 |
| Kodani, M | 1 |
| Hitsuda, Y | 1 |
| Shimizu, E | 1 |
| Sugawara, H | 1 |
| Ichiki, M | 1 |
| Sai, K | 1 |
| Kamata, K | 1 |
| Ansai, M | 1 |
| Nakano, Y | 1 |
| Kawamura, M | 1 |
| Ichinose, A | 1 |
| Miyazaki, S | 1 |
| Sato, Y | 3 |
| Takayama, T | 1 |
| Sagawa, T | 1 |
| Ohnuma, H | 1 |
| Okubo, S | 2 |
| Shintani, N | 1 |
| Kida, M | 1 |
| Ohta, H | 2 |
| Miyanishi, K | 1 |
| Sato, T | 1 |
| Takimoto, R | 1 |
| Kobune, M | 1 |
| Yamaguchi, K | 1 |
| Niitsu, Y | 1 |
| Kato, J | 1 |
| Furuichi, M | 1 |
| Muramatsu, T | 1 |
| Shimamura, M | 1 |
| Nishii, T | 1 |
| Takeshita, S | 1 |
| Ishimoto, S | 1 |
| Morooka, H | 1 |
| Sodeyama, M | 1 |
| Sakurai, K | 3 |
| Amano, S | 2 |
| Ohmori, I | 1 |
| Shiono, M | 1 |
| Matsuda, S | 1 |
| Takahashi, M | 1 |
| Watanabe, J | 1 |
| Yabuno, T | 1 |
| Mochizuki, Y | 1 |
| Kito, F | 1 |
| Kao, PS | 1 |
| Chang, SC | 1 |
| Wang, LW | 1 |
| Lee, RC | 1 |
| Liang, WY | 1 |
| Lin, TC | 1 |
| Chen, WS | 1 |
| Jiang, JK | 1 |
| Yang, SH | 1 |
| Wang, HS | 1 |
| Lin, JK | 1 |
| Takakura, N | 1 |
| Aoki, H | 2 |
| Fujiwara, Y | 1 |
| Ohno, S | 2 |
| Ninomiya, M | 1 |
| Iitaka, D | 1 |
| Ikoma, H | 1 |
| Kawaguchi, T | 1 |
| Murayama, Y | 1 |
| Kuriu, Y | 1 |
| Nakanishi, M | 1 |
| Ichikawa, D | 1 |
| Ochiai, T | 2 |
| Kokuba, Y | 1 |
| Sonoyama, T | 1 |
| Okada, K | 1 |
| Imaizumi, T | 1 |
| Yazawa, N | 1 |
| Matsuyama, M | 1 |
| Dowaki, S | 1 |
| Tobita, K | 1 |
| Hirabayashi, K | 1 |
| Makuuchi, H | 1 |
| Watanabe, T | 1 |
| Yano, M | 1 |
| Moriyama, S | 1 |
| Kawano, O | 1 |
| Hikosaka, Y | 1 |
| Fujii, Y | 1 |
| Satoh, M | 1 |
| Nakano, O | 1 |
| Kuwahara, M | 1 |
| Ito, A | 1 |
| Arai, Y | 1 |
| Higuchi, M | 1 |
| Suzuki, H | 1 |
| Shio, Y | 1 |
| Satoh, Y | 1 |
| Kitamura, M | 1 |
| Gotoh, M | 2 |
| Maruyama, R | 1 |
| Hirai, F | 1 |
| Ondo, K | 1 |
| Kometani, T | 1 |
| Hamatake, M | 1 |
| Seto, T | 1 |
| Ichinose, Y | 1 |
| Koeda, K | 1 |
| Konosu, M | 1 |
| Hosoi, N | 1 |
| Tamasawa, Y | 1 |
| Sase, M | 1 |
| Tsukahara, T | 1 |
| Ushio, A | 1 |
| Taguchi, M | 1 |
| Wakabayashi, G | 1 |
| Inoue, K | 1 |
| Nakane, Y | 1 |
| Kogire, M | 1 |
| Fujitani, K | 1 |
| Tamura, S | 1 |
| Okano, S | 1 |
| Kwon, AH | 1 |
| Shimokawa, T | 1 |
| Takiuchi, H | 1 |
| Tsujinaka, T | 2 |
| Furukawa, H | 1 |
| Kitasato, Y | 1 |
| Yasunaga, M | 1 |
| Nakayama, M | 1 |
| Akasu, G | 1 |
| Yoshitomi, M | 1 |
| Mikagi, K | 1 |
| Kawahara, R | 1 |
| Ishikawa, H | 2 |
| Hisaka, T | 1 |
| Horiuchi, H | 1 |
| Okabe, Y | 1 |
| Hamakawa, T | 1 |
| Takiguchi, S | 1 |
| Miyata, H | 1 |
| Dok, Y | 1 |
| Sakurai, N | 1 |
| Yamamoto, K | 2 |
| Kakizaki, Y | 1 |
| Tamura, G | 1 |
| Iizawa, H | 1 |
| Sakabe, R | 1 |
| Nakashima, A | 1 |
| Ohge, H | 1 |
| Hiyama, E | 1 |
| Katoh, R | 1 |
| Takeyoshi, I | 1 |
| Sunose, Y | 1 |
| Yoshinari, D | 1 |
| Totsuka, O | 1 |
| Toya, H | 1 |
| Ogawa, H | 1 |
| Hirai, K | 1 |
| Mori, Y | 1 |
| Ohtani, H | 1 |
| Tamamori, Y | 1 |
| Inoue, T | 1 |
| Azuma, T | 1 |
| Yamamoto, Y | 2 |
| Nakai, N | 1 |
| Wakabayashi, Y | 1 |
| Okuzawa, Y | 1 |
| Asai, J | 1 |
| Takenaka, H | 1 |
| Katoh, N | 1 |
| Takii, M | 1 |
| Kuroda, K | 2 |
| Asano, Y | 1 |
| Noda, E | 1 |
| Yamada, N | 1 |
| Umemoto, S | 1 |
| Hosaka, S | 1 |
| Kikutake, T | 1 |
| Maeno, H | 1 |
| Nagao, S | 1 |
| Kawamoto, S | 1 |
| Yoshida, T | 2 |
| Kaneko, S | 1 |
| Itsui, Y | 1 |
| Hashiguchi, M | 1 |
| Watanabe, M | 2 |
| Yoshida, R | 1 |
| Akashi, T | 1 |
| Yauchi, T | 1 |
| Yamamoto, S | 2 |
| Nakamura, K | 1 |
| Katai, H | 1 |
| Nashimoto, A | 1 |
| Fukushima, N | 1 |
| Abe, S | 1 |
| Kojima, M | 1 |
| Kurihara, H | 1 |
| Tamura, H | 1 |
| Kitago, M | 1 |
| Sasanuma, H | 1 |
| Wada, M | 1 |
| Ogihara, T | 1 |
| Ohchi, T | 1 |
| Kudo, S | 1 |
| Ogata, K | 1 |
| Nakamura, T | 1 |
| Koga, Y | 1 |
| Ishiodori, H | 1 |
| Ishihara, A | 1 |
| Feliu, J | 1 |
| Mel, R | 1 |
| Borrega, P | 1 |
| López Gómez, L | 1 |
| Escudero, P | 1 |
| Dorta, J | 1 |
| Castro, J | 1 |
| Vázquez-Estévez, SE | 1 |
| Bolaños, M | 1 |
| Espinosa, E | 1 |
| González Barón, M | 1 |
| Tanaka, A | 1 |
| Funai, S | 1 |
| Ohtsuka, H | 1 |
| Yoshifuji, T | 1 |
| Hirai, T | 2 |
| Shindo, K | 1 |
| Shiozaki, H | 1 |
| Kamei, A | 1 |
| Egawa, T | 1 |
| Nagashima, A | 1 |
| Kitano, M | 1 |
| Doi, M | 1 |
| Hayashi, S | 2 |
| Yoshii, H | 1 |
| Nakajima, Y | 1 |
| Gotanda, T | 1 |
| Uchimiya, H | 1 |
| Furukawa, T | 1 |
| Haraguchi, M | 1 |
| Ikeda, R | 1 |
| Sumizawa, T | 1 |
| Akiyama, S | 1 |
| Ohwada, S | 1 |
| Ikeya, T | 1 |
| Yokomori, T | 1 |
| Kusaba, T | 1 |
| Roppongi, T | 1 |
| Nakamura, S | 2 |
| Kakinuma, S | 1 |
| Iwazaki, S | 1 |
| Kawate, S | 1 |
| Nakajima, T | 2 |
| Morishita, Y | 1 |
| Nakayama, H | 1 |
| Aoki, N | 1 |
| Karube, H | 1 |
| Ogame, H | 1 |
| Masuda, H | 1 |
| Hemmi, A | 1 |
| Obara, S | 1 |
| Mishima, K | 1 |
| Yoshimura, Y | 1 |
| Kamoshida, S | 1 |
| Matsuoka, H | 1 |
| Ishikawa, T | 1 |
| Shimomura, R | 1 |
| Tsutsumi, Y | 1 |
| Deguchi, Y | 1 |
| Shioya, M | 1 |
| Sakai, M | 1 |
| Takenaka, K | 1 |
| Doi, H | 1 |
| Komai, Y | 1 |
| Higuchi, A | 1 |
| Yasuda, A | 1 |
| Mizuno, I | 1 |
| Mohri, N | 1 |
| Matsumoto, K | 1 |
| Fukaya, S | 1 |
| Shinagawa, N | 1 |
| Manabe, T | 1 |
| Ogata, Y | 2 |
| Matono, K | 2 |
| Sasatomi, T | 1 |
| Ishibashi, N | 2 |
| Ohkita, A | 1 |
| Mizobe, T | 2 |
| Ogo, S | 1 |
| Ikeda, S | 2 |
| Ozasa, H | 2 |
| Shirouzu, K | 2 |
| Yoneyama, K | 1 |
| Sugano, N | 1 |
| Jin, Y | 1 |
| Kasahara, A | 1 |
| Takanashi, Y | 2 |
| Yamada, K | 1 |
| Sugiyama, Y | 1 |
| Seino, K | 1 |
| Kobori, H | 1 |
| Ebina, T | 1 |
| Shibata, S | 1 |
| Kawasaki, H | 1 |
| Sasaki, M | 1 |
| Takagi, T | 1 |
| Ueda, N | 1 |
| Kanemoto, H | 1 |
| Shoji, T | 1 |
| Fukasawa, T | 1 |
| Kikuchi, Y | 1 |
| Mori, S | 1 |
| Akagi, Y | 1 |
| Murakami, H | 2 |
| Shirakawa, T | 1 |
| Yokoi, K | 1 |
| Ishikawa, N | 1 |
| Seya, T | 1 |
| Horiba, K | 1 |
| Kanazawa, Y | 1 |
| Okawa, K | 1 |
| Yoshioka, M | 1 |
| Oaki, Y | 1 |
| Tokunaga, A | 1 |
| Tajiri, T | 1 |
| Kobayashi, K | 1 |
| Ueki, K | 1 |
| Wakakuwa, R | 1 |
| Ishizuka, D | 1 |
| Tada, T | 1 |
| Tsuji, K | 1 |
| Honda, S | 1 |
| Yamasaki, N | 1 |
| Hiramatsu, K | 1 |
| Kato, K | 1 |
| Hirata, A | 1 |
| Matsuba, H | 1 |
| Hara, T | 1 |
| Miyata, T | 1 |
| Akagawa, T | 1 |
| Kutsuna, Y | 1 |
| Machiki, Y | 1 |
| Fujioka, S | 1 |
| Toyooka, M | 1 |
| Saze, Z | 1 |
| Terashima, M | 1 |
| Otani, S | 1 |
| Soeta, N | 1 |
| Kashimura, S | 1 |
| Osuka, F | 1 |
| Odashima, Y | 1 |
| Saito, T | 1 |
| Hoshino, Y | 1 |
| Kogure, M | 1 |
| Watanabe, K | 1 |
| Doi, T | 1 |
| Okuda, T | 2 |
| Fujimi, A | 1 |
| Kanisawa, Y | 1 |
| Izumi, K | 1 |
| Kitahara, T | 1 |
| Rivera, F | 1 |
| Vega-Villegas, ME | 1 |
| López-Brea, M | 1 |
| Isla, D | 1 |
| Mayorga, M | 1 |
| Galdós, P | 1 |
| Rubio, A | 1 |
| Del Valle, A | 1 |
| García-Reija, F | 1 |
| García-Montesinos, B | 1 |
| Rodríguez-Iglesias, J | 1 |
| Mayordomo, J | 1 |
| Rama, J | 1 |
| Saiz-Bustillo, R | 1 |
| Sanz-Ortiz, J | 1 |
| Tokuhara, T | 1 |
| Sakata, C | 1 |
| Nishikawa, M | 2 |
| Morita, R | 1 |
| Yamakawa, M | 1 |
| Han, I | 1 |
| Hatori, S | 1 |
| Iwasaki, H | 1 |
| Tazawa, K | 1 |
| Matsui, K | 1 |
| Shinbo, M | 1 |
| Yamagishi, F | 1 |
| Yamada, A | 1 |
| Tsukada, K | 1 |
| Enomoto, K | 1 |
| Kitajima, A | 1 |
| Tani, M | 1 |
| Masuyama, K | 1 |
| Oonishi, Y | 1 |
| Sawataishi, M | 1 |
| Suzuki, S | 1 |
| Yamazaki, K | 1 |
| Ishizawa, S | 1 |
| Wakaki, K | 1 |
| Ohkawa, S | 1 |
| Itoh, Y | 1 |
| Tamai, S | 1 |
| Tarao, K | 1 |
| Sasaki, A | 1 |
| Furusawa, M | 1 |
| Tomoda, H | 1 |
| Seo, Y | 1 |
| Matsukuma, A | 1 |
| Kakeji, Y | 1 |
| Hirata, T | 1 |
| Yamagishi, S | 1 |
| Hirano, S | 1 |
| Kutsukata, N | 1 |
| Masuda, S | 1 |
| Hisayoshi, T | 1 |
| Hioki, M | 1 |
| Choi, S | 1 |
| Okada, F | 1 |
| Kobayashi, M | 1 |
| Habelhah, H | 1 |
| Nakae, D | 1 |
| Konishi, Y | 1 |
| Totsuka, Y | 1 |
| Hosokawa, M | 1 |
| Maeda, O | 1 |
| Iwase, H | 1 |
| Mamiya, N | 1 |
| Mizuno, T | 1 |
| Nishio, Y | 1 |
| Ando, T | 1 |
| Ina, K | 1 |
| Kusugami, K | 1 |
| Tokunaga, Y | 1 |
| Kitaoka, A | 1 |
| Yagi, T | 1 |
| Tokuka, A | 1 |
| Ohsumi, K | 1 |
| Liu, J | 1 |
| Ikeguchi, M | 1 |
| Kaibara, N | 1 |
| Hartwich, G | 1 |
| Hayashi, J | 1 |
| Hidaka, N | 1 |
| Sanda, M | 1 |
| Ohashi, N | 1 |
| Yajima, Y | 1 |
| Furukawa, Y | 1 |
| Kato, M | 1 |
| Takiguchi, N | 1 |
| Niimoto, M | 1 |
| Saeki, T | 1 |
| Toi, M | 1 |
| Nishiyama, M | 1 |
| Yanagawa, E | 1 |
| Hattori, T | 1 |
| Nakanishi, T | 1 |
| Nagase, T | 1 |
| Nakagawa, C | 1 |
| Maeda, S | 1 |
| Tokunaga, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Study of Paclitaxel Liposome Plus S-1 as Neoadjuvant Chemotherapy for Advanced Gastric Cancer[NCT02163291] | Phase 2 | 30 participants (Anticipated) | Interventional | 2013-12-31 | Not yet recruiting | ||
| Adjuvant Chemotherapy Versus Observation in Fully Resected Stage I Lung Adenocarcinoma With High Risk of Post-operative Recurrence[NCT03380468] | Phase 2/Phase 3 | 300 participants (Anticipated) | Interventional | 2018-01-01 | Recruiting | ||
| Apatinib Plus XELOX Regime as Neoadjuvant Therapy in Locally Advanced Gastric Cancer Patients With Lymph Node Metastasis[NCT03229096] | Phase 2 | 35 participants (Anticipated) | Interventional | 2017-02-01 | Recruiting | ||
| The Exploratory Study of Conversion Surgery for Apatinib in Combination With Oxaliplatin/S-1(SOX) for Patients With Unresectable Gastric Cancer[NCT03007446] | Phase 2 | 20 participants (Anticipated) | Interventional | 2016-11-30 | Recruiting | ||
| Phase III Randomized Controlled Clinical Study of UFT/LV Therapy Versus UFT/LV + PSK Therapy as Postoperative Adjuvant Therapy for Histological Stage IIIa and IIIb Colorectal Cancer[NCT00497107] | Phase 3 | 300 participants (Anticipated) | Interventional | 2007-07-31 | Recruiting | ||
| A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer[NCT00385970] | Phase 3 | 380 participants (Anticipated) | Interventional | 2006-03-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for tegafur and Invasiveness, Neoplasm
| Article | Year |
|---|---|
[A case of locally advanced gastric cancer in which pathological complete response( PCR) was obtained after combination chemotherapy with S-1/cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastric Bypass; | 2013 |
[An Elderly Patient with Local Recurrence of Gastric Cancer Responding Completely to S-1 Monotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Gastrectomy; Humans; Lymphati | 2016 |
[Locally recurrent case of gastric cancer with serosal invasion after four months of endoscopic submucosal dissection].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Endos | 2012 |
14 trials available for tegafur and Invasiveness, Neoplasm
| Article | Year |
|---|---|
A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Vessels; Carcinoma, Non-Small-Cell Lung; | 2020 |
Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).
Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplas | 2018 |
Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; H | 2014 |
Concurrent radiotherapy with S-1 plus cisplatin versus concurrent radiotherapy with cisplatin alone for the treatment of locally advanced cervical carcinoma: a pilot randomised controlled trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Drug Combinations; Fem | 2016 |
A Phase II Study of Adjuvant Chemotherapy of Tegafur-Uracil for Patients with Breast Cancer with HER2-negative Pathologic Residual Invasive Disease After Neoadjuvant Chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 2016 |
A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Comb | 2009 |
UFT plus vinorelbine in advanced non-small cell lung cancer: a phase I and an elderly patient-directed phase II study.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non | 2009 |
Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogen | 2010 |
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2012 |
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2012 |
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2012 |
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2012 |
Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adminis | 2013 |
Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Deoxycy | 2002 |
Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 2004 |
Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 2004 |
Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 2004 |
Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 2004 |
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Su | 2008 |
Prospective randomized controlled study on bestatin in resectable gastric cancer--third report.
Topics: Adjuvants, Immunologic; Aminopeptidases; Antibiotics, Antineoplastic; Antineoplastic Combined Chemot | 1990 |
97 other studies available for tegafur and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cycloph | 2019 |
Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy.
Topics: Aged; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Digestive System Surgical Proced | 2019 |
Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancer.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Survival; Disease-Free Survival; D | 2020 |
Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy.
Topics: Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycyti | 2020 |
[A Case of Duodenal Invasive Advanced Gastric Cancer in Which the Primary Tumor Achieved pCR, but Viable Cancer Cells Remained in Lymph Node No.13 after Neoadjuvant Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Duodenum; Female; Gastrecto | 2017 |
[Laparoscopic Total Gastrectomy with Pancreatosplenectomy after Neoadjuvant Chemotherapy for Advanced Gastric Cancer with Adjacent Organs Invasion].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Hum | 2017 |
Gallbladder cancer with tumor thrombus in the portal vein: A case report.
Topics: Administration, Intravenous; Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; D | 2018 |
[A Case of Type 4 Gastric Cancer with Esophageal Invasion That Responded to Neoadjuvant Chemotherapy Containing S-1 and Oxaliplatin followed by Surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Esophagus; Gastrectomy | 2018 |
Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; | 2013 |
[A case of advanced gastric cancer with esophageal invasion treated by neoadjuvant S-1/CDDP chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Esophagus; Gastr | 2013 |
[A case of locally advanced pancreatic cancer with hepatic artery invasion treated with neoadjuvant chemoradiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Deoxycytidine; Drug Combinations; | 2013 |
[A case of combined resection of multiple adjacent organs in a patient with locally advanced residual gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2013 |
Repeat hepatectomy for intrahepatic recurrence of cholangiolocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; | 2013 |
Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetu | 2014 |
Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemot | 2014 |
[A case of a patient with gastric cancer and peritoneal dissemination who survived for more than 10 years after successful treatment with S-1].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Female; Gastrectomy; | 2014 |
[A case of gastric cancer with N2 lymph node metastasis and pancreatic invasion effectively treated with docetax-el/S-1 as a neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lymphati | 2014 |
Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, | 2014 |
Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Mod | 2014 |
Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 2015 |
[Two cases of advanced gastric cancer achieved pathological complete response by preoperative chemotherapy with S-1 plus weekly low-dose CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2014 |
[A case report of advanced gastric cancer with bulky lymph node metastases successfully treated with induction chemotherapy followed by curative resection].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; Induction Che | 2014 |
[Pathological complete response in a case of advanced gastric cancer after neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Humans; M | 2014 |
Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biom | 2015 |
Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2015 |
[A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy].
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Drug Combinations; Fatal Outcome; Female; Gemcitabin | 2015 |
S-1 Adjuvant Chemotherapy Earlier After Surgery Clinically Correlates with Prognostic Factors for Advanced Gastric Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Com | 2016 |
[A Case of Long-Term Survival after Pancreatoduodenectomy for Gastric Cancer with Pancreatic Invasion].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; Neoplasm Inva | 2015 |
[A Case of Invasive Intraductal Papillary Mucinous Carcinoma, Penetrating the Stomach, Colon, and Jejunum].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Chemotherapy, Ad | 2015 |
The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cape | 2016 |
[Curative Resection for Chemorefractory Advanced Gastric Cancer with Pancreatic Invasion by Pancreatoduodenectomy - A Case Report].
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothec | 2016 |
Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2017 |
[Case of esophageal cancer successfully performed in early response evaluation for preoperative chemotherapy by FDG-PET].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Ci | 2008 |
[S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma].
Topics: Aged; Angiography; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Deoxycytidine; | 2008 |
Laparoscopic resection of extraperitoneal rectal cancer: a comparative analysis with open resection.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Mod | 2009 |
[Noticeable clinical response to S-1/CDDP combination therapy for Virchow node recurrence after surgery for advanced gastric carcinoma with marked involvement of the esophagus - report of a case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Drug Combination | 2009 |
[Treatment with S-1 and radiation therapy for advanced lung cancer invading chest wall].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Humans; Lung Neoplasm | 2010 |
[A case report of bi-weekly docetaxel and S-1 combination chemotherapy for gastric cancer with multiple liver metastases and esophageal invasion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Esophageal Neoplasms; | 2010 |
The impact of preoperative chemoradiotherapy on advanced low rectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 2010 |
[A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy].
Topics: Combined Modality Therapy; Deoxycytidine; Drug Combinations; Fatal Outcome; Gemcitabine; Humans; Lym | 2010 |
[A case report--locally advanced pancreatic adenocarcinoma was resected after chemotherapy].
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Combined M | 2010 |
Curative surgical treatment after preoperative chemotherapy for primarily inoperable locally advanced pancreatic carcinoma: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Female; Gemcitabin | 2009 |
Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv | 2011 |
Prognostic factors of pathologic stage IB non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Che | 2011 |
[A case of marked efficacy of low-dose UFT against metastatic bladder cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 2011 |
A case of gastric cancer accompanied with massive splenic invasion by metastatic lymph nodes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Endoscopy, Digestive S | 2011 |
[A case of long-term survival after resection of aortic arch for locally advanced non-small cell lung cancer with induction chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Thoracic; Carcinoma, Non-Small-Cell Lung; Cis | 2011 |
Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm | 2011 |
[A case of advanced adenocarcinoma of esophagogastric junction with severe esophageal invasion effectively treated by chemoradiotherapy using paclitaxel and cisplatin, and S-1 after chemoradiotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality T | 2011 |
[A case of peritoneal recurrence of invasive carcinoma derived from IPMN after distal pancreatectomy].
Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Chemoradiotherapy; Deoxycytidine; Drug Combinat | 2011 |
[Combination chemotherapy using docetaxel, cisplatin, and S-1 for far advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations | 2011 |
[A case of curatively resected locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Fatal Outcom | 2012 |
Prognostic significance of telomerase activity and human telomerase reverse transcriptase expression in ampullary carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Antineoplastic Agents; Biomarkers, Tumor; Carcinom | 2012 |
[A case of pancreatic cancer with celiac trunk and common hepatic artery invasion successfully resected after gemcitabine+S-1therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Celiac Artery; Deoxycytidine; Drug Combinations; Fem | 2012 |
[Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Liver Ne | 2012 |
A case of advanced cutaneous squamous cell carcinoma of the lower eyelid that was successfully treated with tegafur-gimeracil-oteracil potassium monotherapy.
Topics: Administration, Oral; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; | 2012 |
[A case of advanced gastric cancer with esophageal severe dysplasia resected after neoadjuvant S-1+cisplatin therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Esophageal Neopl | 2012 |
[A case of gastric neuroendocrine carcinoma with liver metastasis and portal vein invasion successfully treated by S-1 and cisplatin chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cisplatin; Drug C | 2013 |
[A case of residual gastric cancer accompanied by esophageal invasion in which residual lesions were eradicated by half-dose administration of TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Drug Combinations; Esophageal Neoplasms; Gastrectom | 2002 |
[A case of advanced gastric cancer with invasion of pancreas effectively treated by combined chemotherapy of TS-1 and paclitaxel (TXL)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule | 2002 |
[A patient with advanced gastric cancer that response remarkably to combination chemotherapy of TS-1 and biweekly paclitaxel (TXL)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Drug Administration S | 2003 |
[A case of advanced gastric cancer that had invaded the duodenum treated with combined chemotherapy using TS-1 and low-dose CDDP, which prevented the need for a pancreaticoduodenectomy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relat | 2003 |
Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose.
Topics: Animals; Apoptosis; Deoxyribose; Drug Therapy, Combination; Interleukin-8; Liver Neoplasms; Male; Mi | 2004 |
[A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryo | 2004 |
[An advanced case of squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to chemotherapy with TS-1].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administrat | 2004 |
Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; C | 2004 |
[A case of advanced gastric cancer with pulmonary carcinomatous lymphangiosis responding remarkably to combination chemotherapy of docetaxel (TXT) and TS-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Sched | 2005 |
[Successfully resected advanced gastric carcinoma after combined chemotherapy of TS-1 plus CDDP--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality T | 2005 |
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemo | 2006 |
[A case of advanced gastric cancer effectively treated by combined chemotherapy of TS-1 and paclitaxel].
Topics: Aged; Anastomosis, Roux-en-Y; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant | 2005 |
[A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; | 2005 |
[Effective treatment of unresectable advanced gastric cancer by TS-1-based chemotherapy with a sequential combination of cisplatin (CDDP) and paclitaxel (PTX)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2005 |
[A case of gastric cancer with liver invasion responding to TS-1/low-dose CDDP chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2005 |
The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemo | 2006 |
[A case of advanced gastric cancer successfully treated by TS-1 and CDDP after jejunostomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Admini | 2006 |
[A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb | 2006 |
Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; | 2007 |
[A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Squamous Cell; C | 2007 |
[A case of effective regimen of tegafur and uracil (UFT)/leucovorin (LV) plus irinotecan (CPT-11) for advanced rectal carcinoma with severe pelvic infiltration to be performed curative resection].
Topics: Adenocarcinoma; Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Pr | 2007 |
[A case of advanced gastric cancer responding remarkably to neo-adjuvant combination chemotherapy using CPT-11 plus S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2007 |
[A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Deoxycytidine; Drug Combinations; Female | 2007 |
[Resection of cancer of the cardia enabled by combined treatment with S-1 and paclitaxel after esophageal stenting for impaired patency complicating stage IV gastric cancer - a case report].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic C | 2007 |
[Neoadjuvant chemotherapy with combination of S-1 and CPT-11 in advanced rectal cancer - a case report].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemothe | 2007 |
[A case of unresectable gastric cancer presenting pylorus stenosis treated orally with S-1 therapy after gastrojejunostomy].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Constriction, Pathologic; Drug Administ | 2007 |
[A case of advanced breast cancer successfully treated with multi-disciplinary therapy and S-1 administration].
Topics: Biopsy, Needle; Breast Neoplasms; Drug Combinations; Female; Humans; Magnetic Resonance Imaging; Mid | 2007 |
[A case of small cell carcinoma of the stomach with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; | 1994 |
[A case of hepatocellular carcinoma with portal invasion and right adrenal gland metastasis showing marked contraction of primary tumor and metastasis with treated by UFT alone].
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocell | 1994 |
[Effect of adjuvant chemotherapy for patients with early gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 1994 |
[A case of far-advanced gastric cancer treated with neoadjuvant combination chemotherapy of UFT, low-dose CDDP and leucovorin, followed by subtotal gastrectomy with curative intent].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemotherapy, Adjuvant; C | 1997 |
Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemotaxis; Cisplatin; Clone Cells; Drug Co | 1999 |
Scirrhous cancer of the stomach which survived for more than five years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin.
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuv | 2000 |
Postsurgical sequential methotrexate, fluorouracil, and leucovorin for stages 3 and 4 gastric carcinoma: A preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Sc | 2000 |
Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha Catenin; Antineoplastic Combined Chemotherapy | 2002 |
Chemotherapy of gastrointestinal cancer.
Topics: Adjuvants, Pharmaceutic; Antineoplastic Agents; Fluorouracil; Gastrointestinal Neoplasms; Humans; Ne | 1979 |
[A effective combination preoperative intraarterial infusion chemotherapy and irradiation for advanced sigmoid colon cancer with bladder invasion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality | 1992 |
[Histopathological findings in rectal carcinomas undergoing preoperative irradiation combined with chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Male; | 1992 |
[A case of hepatocellular carcinoma with extrahepatic portal vein obstruction due to tumor invasion, responsive to oral administration of UFT].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellul | 1987 |